By modulating interactions of nesprin-2, Mena controls phosphorylation of the nuclear membrane protein emerin, repositioning of chromatin at the nuclear periphery and the regulation of some genes involved in tumour progression (proposed model in Fig. 5). The gene discussed is EMD; the disease is neoplasm.